WST
West Pharmaceutical Services, Inc.

857
Loading...
Loading...
News
all
press releases
HTFL Gains FDA Clearance & Cigna Coverage for Next Gen Plaque Analysis
Heartflow secures FDA clearance and Cigna coverage for its Next Gen Plaque Analysis, boosting accuracy and nationwide access.
Zacks·4d ago
News Placeholder
More News
News Placeholder
TMDX Partners With Mercedes-Benz to Launch Organ Transport Network
TransMedics collaborates with Mercedes-Benz to launch Italy's first organ transport network, expanding its OCS model beyond the United States.
Zacks·8d ago
News Placeholder
STXS Stock Gains as Erasmus Medical Adopts Its Genesis Robotic System
Stereotaxis stock gains as Erasmus Medical adopts Genesis robotic system, marking a milestone in cardiac arrhythmia care.
Zacks·10d ago
News Placeholder
Reasons to Hold Fresenius Medical Stock in Your Portfolio for Now
FMS acquisitions, partnerships and global reach fuel growth, though rising costs weigh on near-term prospects.
Zacks·10d ago
News Placeholder
Here's Why You Should Add Inogen Stock to Your Portfolio Now
Expanding product portfolio and high prospects for POC raise optimism for INGN stock.
Zacks·10d ago
News Placeholder
Stryker Expands R&D Facility in India to Boost Medtech Innovation
SYK expands its Bangalore R&D hub to accelerate robotics, AI and digital health innovation while deepening ties with India's talent pool.
Zacks·11d ago
News Placeholder
Reasons to Hold AngioDynamics Stock in Your Portfolio for Now
ANGO benefits from NanoKnife, clinical milestones and a balanced portfolio despite tariff headwinds.
Zacks·11d ago
News Placeholder
Reasons to Retain Cooper Companies Stock in Your Portfolio for Now
COO's premium lens strategy, MiSight myopia leadership, and fertility portfolio fuel long-term growth despite near-term headwinds.
Zacks·11d ago
News Placeholder
SGHT Shares Rise on Meta-Analysis Showing OMNI's Long-Term Benefits
Sight Sciences highlights a new meta-analysis showing OMNI delivers lasting safety, efficacy and economic value in glaucoma treatment.
Zacks·14d ago
News Placeholder
Here's Why You Should Hold Accuray Stock in Your Portfolio for Now
ARAY sees strong order momentum, APAC growth and CyberKnife demand, but soft product sales and regional headwinds cloud near-term gains.
Zacks·15d ago

Latest WST News

View

Advertisement|Remove ads.

Advertisement|Remove ads.